Yeztugo (Lenacapavir) Inj. 463.5mg/1.5ml X 2Vials

Lenacapavir is an advanced antiretroviral medication developed for the treatment and prevention of Human Immunodeficiency Virus Type 1 (HIV-1). It belongs to a new class of HIV drugs known as capsid inhibitors, designed to interfere with multiple stages of the HIV life cycle. Unlike many traditional HIV medications that require daily dosing, Lenacapavir is notable for its long-acting formulation, which can be administered as an injection every six months, improving convenience, treatment adherence, and long-term viral suppression.

Developed by Gilead Sciences, Lenacapavir works by targeting the HIV capsid protein — a protective shell surrounding the virus’s genetic material. By disrupting the capsid, the drug prevents HIV from replicating and infecting healthy immune cells. This unique mechanism makes Lenacapavir highly effective, especially for individuals with multidrug-resistant HIV strains who may have limited treatment options.

Lenacapavir is commonly used in combination with other antiretroviral therapies (ART) for heavily treatment-experienced patients whose HIV infection is difficult to manage with conventional medications. Clinical studies have shown that the drug significantly reduces viral load and helps patients achieve improved immune system function. Due to its extended-release nature, it also reduces the burden of daily pill intake and supports better medication compliance.

In addition to HIV treatment, Lenacapavir has gained global attention for its potential role in HIV prevention strategies, including pre-exposure prophylaxis (PrEP). Researchers and healthcare professionals consider it one of the most promising long-acting HIV innovations in modern medicine because of its ability to provide prolonged protection and improve healthcare accessibility. It reduces the risk of sexually acquired HIV in adults and adolescents weighing at least 35kg who are at risk of HIV acquisition.

Individuals must have a negative HIV-1 test prior to initiating Yeztugo.

Common side effects associated with include nausea, injection-site reactions, headache, fatigue, and mild gastrointestinal discomfort. As with all prescription medications, its use should be supervised by qualified healthcare professionals to ensure safety, effectiveness, and appropriate monitoring.